Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q2 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.